目录号 | 产品详情 | 靶点 | |
---|---|---|---|
T18605 | Others | ||
PROTAC ERα Degrader-2 comprises a cIAP1 ligand binding group, a linker and an estrogen receptor α (ERα) binding group. PROTAC ERα Degrader-2 is an ERα degrader. Maximal ERα degradation at 30 μM concentration in human mammary tumor MCF7 cells. Degradation inducers based on cIAP1 are called specific and non-genetic IAP-dependent protein erasers (SNIPERs)[1]. | |||
T68378 | Histone Methyltransferase | ||
PRMT4-IN-1为PRMT4高选择性抑制剂(IC50=3.2 nM),能有效降低MCF7细胞的相对活力。 | |||
T36968 | Topoisomerase | ||
ARN-21934 是高选择性的人拓扑异构酶 II α 抑制剂,具有血脑屏障通透性。依托泊苷抑制 DNA 松弛的IC50为120 μM,ARN-21934 抑制 DNA 松弛的IC50为 2 μM。ARN-21934具有良好的体内药代动力学特性。 | |||
T63401 | |||
EGFR/HER2/TS-IN-1 是 EGFR、HER2和TS (Thymidylate synthase)抑制剂,他们的IC50值分别为 0.203、0.088 和 0.168 μM,具有诱导 MCF7 细胞凋亡(apoptosis)的作用。 | |||
T72844 | |||
EGFR/CDK2-IN-1 (化合物 3b) 是一种 EGFR/CDK2抑制剂。EGFR/CDK2-IN-1 对 MCF7 和 HepG2 细胞显示出较强的细胞毒性。EGFR/CDK2-IN-1 可用于癌症的研究。 | |||
T81688 | |||
Neohelmanthicin B,一种从Thapsia garganica提取的苯丙素,对EL4、S180和MCF7细胞系展现出显著的细胞毒性作用,其IC50值分别为10、5和12 μM。 | |||
T81740 | Trk receptor | ||
Multi-kinase-IN-6 (compound 10e) 是一种效能极高的多激酶抑制剂,具有对 TrkA、ALK2、c-KIT、EGFR、PIM1、CK2α、CHK1 和 CDK2 等多种酶的显著抑制作用。在 MCF7、HCT116 和 EKVX 癌细胞系上,其抗增殖活性突出,IC50 值分别达到 3.36 μM、1.40 μM 与 3.49 μM。此外,Multi-kinase-IN-6 能引起 MCF7 与 HCT116 细胞的细胞周期在 G1/S 期及 G1 期停滞,并有效诱导凋亡。 | |||
T79083 | HSP | ||
HSP90-IN-22(Compound 35)作为Hsp90抑制剂,对MCF7乳腺癌细胞的IC50为3.65μM,对SKBr3乳腺癌细胞的IC50为2.71μM,显示出对这些细胞系具有显著的抗增殖活性。 | |||
TN3834 | Antifection | ||
Derrone may be interesting antimicrobial agents to be used against infectious diseases caused by many pathogens. It is also a novel Aurora kinase inhibitor, it can significantly inhibit the formation and growth of MCF7 tumor spheroids. | |||
T81962 | Monocarboxylate transporter | ||
Lactate transporter 1 (compound 1) 作为一种活性乳酸运输蛋白,主要在活细胞内发挥作用。在Hela、CAL27、MCF7和MCF10A细胞系中,Lactate transporter 1 均显示出了明显的毒性,其半抑制浓度(IC50)值依次为3.36、3.27、5.58和7.66 μM。此外,在HeLa细胞中,Lactate transporter 1 与Cisplatin表现出了协同抑制的作用。 |
目录号 | 产品名/同用名 | 种属 | 表达系统 | ||
---|---|---|---|---|---|
TMPK-00785 | ANXA2 Protein, Mouse, Recombinant (His) | Mouse | E. coli | ||
ANXA2, highly expressed in invasive breast cancer cells, is closely related with poor prognosis, and acts as a molecular switch to EGFR activation. ANXA2 expression is inversely correlated with cell sensitivity to gefitinib. Knockdown of ANXA2 expression in MDA-MB-231 cells increased the gefitinib induced cell death. When ANXA2 was overexpressed in MCF7 cells, the gefitinib induced cell death was decreased. Furthermore, the phosphorylation of ANXA2 at Tyr23 is negatively correlated with the sensitivity of TNBC to gefitinib.
|
|||||
TMPK-00784 | ANXA2 Protein, Human, Recombinant (His) | Human | E. coli | ||
ANXA2, highly expressed in invasive breast cancer cells, is closely related with poor prognosis, and acts as a molecular switch to EGFR activation. ANXA2 expression is inversely correlated with cell sensitivity to gefitinib. Knockdown of ANXA2 expression in MDA-MB-231 cells increased the gefitinib induced cell death. When ANXA2 was overexpressed in MCF7 cells, the gefitinib induced cell death was decreased. Furthermore, the phosphorylation of ANXA2 at Tyr23 is negatively correlated with the sensitivity of TNBC to gefitinib.
|